Newsroom
Sorted by: Latest
-
MSI Launches Standalone Canine Liability Insurance for Landlords and Property Managers
TAMPA, Fla.--(BUSINESS WIRE)--MSI™ today announced the launch of its canine liability insurance solution, a standalone product designed for residential landlords and property managers. By giving landlords a simple, affordable way to manage liability arising from dog bites, this insurance product creates a win on both sides of the lease: landlords gain the confidence to open their properties to pet-owning tenants, and renters with dogs gain access to more housing options. The product provides li...
-
Juicebox Named to the Inaugural Prosumer AI 40
SAN FRANCISCO--(BUSINESS WIRE)--Juicebox, the leading AI recruiting platform, today earned a spot on the inaugural Prosumer AI 40, a new annual list from Notable Capital recognizing the AI tools and applications giving a new generation of workers the ability to build, create, and operate at a level that was simply out of reach before. Produced in partnership with Nasdaq and selected by 30 leading venture firms, the Prosumer AI 40 tracks a category that is reshaping professional life: AI tools d...
-
Welldoc Brings AI-Powered Cardiometabolic Care to 68 Million Medicare Beneficiaries Through the ACCESS Model and Medicare App Library
COLUMBIA, Md.--(BUSINESS WIRE)--Welldoc®, a leader in AI-powered cardiometabolic health solutions, today announced it has been selected by the Centers for Medicare & Medicaid Services (CMS) to participate in the Advancing Chronic Care with Effective, Scalable Solutions (ACCESS) Model. Welldoc will participate in both the Cardio-Kidney-Metabolic (CKM) and Early CKM (eCKM) tracks, bringing its AI-driven clinical platform to Medicare beneficiaries living with diabetes, obesity, hypertension, a...
-
Obsidian Therapeutics to Present OBX-115 Phase 2 Clinical Data in Advanced Melanoma in Oral Presentation at 2026 ASCO Annual Meeting
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Obsidian Therapeutics, Inc., a clinical-stage biopharmaceutical company harnessing novel protein-regulation technology to develop engineered tumor-infiltrating lymphocyte (TIL) cell therapies, today announced an oral presentation of Phase 2 results in patients with advanced melanoma from the Phase 1/2 Agni-01 multicenter study of OBX-115, at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place in Chicago, IL, May 29–June 2, 2026....
-
Bitwarden Access Intelligence Introduces Reporting for Risk Over Time to Help Organizations Measure and Reduce Credential Exposure
SANTA BARBARA, Calif.--(BUSINESS WIRE)--Bitwarden, the trusted leader in passkey, password, and secrets management, today announced a new reporting capability within Access Intelligence that enables organizations to measure credential risk over time and track remediation progress across applications, items, and members. By introducing historical visibility into how risk evolves, security teams can validate improvements, prioritize future remediation efforts, and demonstrate measurable progress...
-
Rimkus Strengthens Built Environment Leadership to Support Growth Across Canada
HOUSTON--(BUSINESS WIRE)--Rimkus, a global leader in engineering and technical consulting, recently announced two leadership appointments to support the continued growth of its Built Environment Solutions (BES) business across Canada. Walter Gaudet has joined as Vice President of BES Canada, and Michael Hensen has assumed the role of Vice President of Technical Excellence for BES across North America. The appointments come as Canadian public- and private-sector owners accelerate investment in i...
-
Lightcurve Invests in Washington Communities Through Economic Development and Downtown Revitalization Initiatives
TACOMA, Wash.--(BUSINESS WIRE)--Lightcurve, the internet provider delivering the fastest speeds at unbeatable prices across the State of Washington, today announced a series of philanthropic investments supporting economic growth and vibrant downtown communities throughout Central and Western Washington. As part of its ongoing commitment to the communities it serves, Lightcurve has pledged $25,000 to the Tacoma-Pierce County Economic Development Board, reinforcing efforts to drive regional econ...
-
Incyte Highlights New Phase 3 Tafasitamab Data at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting
WILMINGTON, Del.--(BUSINESS WIRE)--Incyte Highlights New Phase 3 Tafasitamab Data at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting...
-
Tenarai Appoints Shashank Samant to its Board of Directors
LOS GATOS, Calif.--(BUSINESS WIRE)--Following its launch as the enterprise AI acceleration company, Tenarai (formerly Infogain), today announced the appointment of Shashank Samant to its Board of Directors, effective immediately. The appointment of Samant, a global leader in digital engineering, AI adoption, and the visionary behind GlobalLogic’s $9.6 billion acquisition by Hitachi, signals Tenarai’s commitment to leading the next era of AI-driven enterprise transformation for the Fortune 500....
-
DWS Delivers Savings to Investors with Fee Reductions on More Than $3 Billion of Assets
NEW YORK--(BUSINESS WIRE)--DWS, a leading European asset manager with global reach, today announced fee reductions on more than $3 billion of mutual fund assets. DWS has lowered expense ratios for five funds across the firm’s Americas Fixed Income and Alternatives platforms, which could potentially save investors more than $2 million in fees annually over time. 1 The fee reductions are effective as of April 21. The Fixed Income and Alternatives platforms are core competencies for DWS Americas....